News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,363 Results
Type
Article (52673)
Company Profile (196)
Press Release (647494)
Multimedia
Podcasts (104)
Webinars (13)
Section
Business (199998)
Career Advice (3367)
Deals (35552)
Drug Delivery (123)
Drug Development (79199)
Employer Resources (188)
FDA (16101)
Job Trends (15371)
News (340535)
Policy (34122)
Tag
2024 BioCapital Digital (2)
2024 BioForest Digital (11)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (14)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (2)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (2)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2880)
Accelerated approval (6)
Adcomms (28)
Allergies (89)
Alliances (48525)
ALS (97)
Alzheimer's disease (1446)
Antibody-drug conjugate (ADC) (145)
Approvals (16065)
Artificial intelligence (277)
Autoimmune disease (27)
Automation (14)
Bankruptcy (352)
Best Places to Work (12199)
BIOSECURE Act (22)
Biosimilars (116)
Biotechnology (126)
Bladder cancer (82)
Brain cancer (31)
Breast cancer (293)
Cancer (2364)
Cardiovascular disease (200)
Career advice (2835)
Career pathing (34)
CAR-T (163)
Cell therapy (454)
Cervical cancer (20)
Clinical research (64182)
Collaboration (872)
Compensation (472)
Complete response letters (29)
COVID-19 (2822)
CRISPR (46)
C-suite (261)
Cystic fibrosis (105)
Data (2240)
Decentralized trials (2)
Denatured (33)
Depression (53)
Diabetes (289)
Diagnostics (6691)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (130)
Drug pricing (124)
Drug shortages (32)
Duchenne muscular dystrophy (99)
Earnings (80929)
Editorial (44)
Employer branding (24)
Employer resources (160)
Events (108835)
Executive appointments (759)
FDA (17372)
Featured Employer (45)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (794)
Gene editing (116)
Generative AI (24)
Gene therapy (339)
GLP-1 (830)
Government (4896)
Grass and pollen (6)
Guidances (59)
Healthcare (20167)
Huntington's disease (24)
IgA nephropathy (31)
Immunology and inflammation (141)
Indications (30)
Infectious disease (2979)
Inflammatory bowel disease (147)
Inflation Reduction Act (11)
Influenza (54)
Intellectual property (99)
Interviews (647)
IPO (17020)
IRA (50)
Job creations (3598)
Job search strategy (2317)
Kidney cancer (11)
Labor market (40)
Layoffs (521)
Leadership (23)
Legal (8516)
Liver cancer (78)
Lung cancer (338)
Lymphoma (157)
Machine learning (7)
Management (63)
Manufacturing (334)
MASH (73)
Medical device (13866)
Medtech (13871)
Mergers & acquisitions (19108)
Metabolic disorders (767)
Multiple sclerosis (83)
NASH (23)
Neurodegenerative disease (111)
Neuropsychiatric disorders (34)
Neuroscience (2031)
NextGen: Class of 2025 (7124)
Non-profit (4903)
Northern California (2639)
Now hiring (38)
Obesity (415)
Opinion (271)
Ovarian cancer (77)
Pain (91)
Pancreatic cancer (83)
Parkinson's disease (157)
Partnered (21)
Patents (239)
Patient recruitment (108)
Peanut (49)
People (58535)
Pharmaceutical (54)
Pharmacy benefit managers (20)
Phase I (19811)
Phase II (28328)
Phase III (21545)
Pipeline (1229)
Policy (169)
Postmarket research (2402)
Preclinical (8321)
Press Release (69)
Prostate cancer (111)
Psychedelics (38)
Radiopharmaceuticals (262)
Rare diseases (419)
Real estate (6025)
Recruiting (73)
Regulatory (22943)
Reports (44)
Research institute (2536)
Resumes & cover letters (555)
Rett syndrome (5)
RNA editing (4)
RSV (50)
Schizophrenia (79)
Series A (141)
Series B (91)
Service/supplier (19)
Sickle cell disease (57)
Southern California (2271)
Special edition (18)
Spinal muscular atrophy (158)
Sponsored (33)
Startups (3946)
State (2)
Stomach cancer (16)
Supply chain (74)
Tariffs (43)
The Weekly (69)
United States (23180)
Vaccines (793)
Venture capitalists (44)
Weight loss (296)
Women's health (34)
Worklife (19)
Date
Today (134)
Last 7 days (867)
Last 30 days (2679)
Last 365 days (33760)
2025 (10839)
2024 (36187)
2023 (41184)
2022 (52535)
2021 (57175)
2020 (56109)
2019 (49596)
2018 (37712)
2017 (34195)
2016 (33478)
2015 (38841)
2014 (29865)
2013 (25467)
2012 (27176)
2011 (27885)
2010 (25371)
Location
Africa (950)
Alabama (58)
Alaska (7)
Arizona (207)
Arkansas (14)
Asia (41047)
Australia (6875)
California (6008)
Canada (1995)
China (536)
Colorado (273)
Connecticut (288)
Delaware (146)
Europe (93941)
Florida (909)
Georgia (215)
Hawaii (1)
Idaho (56)
Illinois (544)
India (28)
Indiana (313)
Iowa (10)
Japan (164)
Kansas (101)
Kentucky (23)
Louisiana (12)
Maine (67)
Maryland (910)
Massachusetts (4595)
Michigan (232)
Minnesota (371)
Mississippi (2)
Missouri (86)
Montana (29)
Nebraska (24)
Nevada (63)
New Hampshire (69)
New Jersey (1753)
New Mexico (26)
New York (1750)
North Carolina (1043)
North Dakota (8)
Northern California (2639)
Ohio (207)
Oklahoma (14)
Oregon (36)
Pennsylvania (1328)
Puerto Rico (13)
Rhode Island (31)
South America (1309)
South Carolina (23)
South Dakota (1)
Southern California (2271)
Tennessee (104)
Texas (889)
Utah (177)
Virginia (149)
Washington D.C. (65)
Washington State (588)
West Virginia (3)
Wisconsin (57)
700,363 Results for "valneva se".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Valneva’s Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and Above
April 2, 2025
·
10 min read
Press Releases
Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities
April 28, 2025
·
6 min read
Press Releases
Valneva Receives First Marketing Authorization for IXCHIQ® in a Chikungunya Endemic Country
April 15, 2025
·
10 min read
Press Releases
Valneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. Travelers
April 18, 2025
·
6 min read
Press Releases
Valneva Announces Filing of 2024 Universal Registration Document and US Form 20-F
March 25, 2025
·
2 min read
Valneva Receives EMA’s Positive CHMP Opinion for its Chikungunya Vaccine
Valneva SE announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending authorization of Valneva’s single-dose vaccine for the prevention of disease caused by the chikungunya virus in individuals 18 years of age and older.
May 31, 2024
·
9 min read
Business
Valneva Announces Successful Outcome of its Combined General Meeting and Appointment of a New Director to its Board
Valneva SE announced that all the resolutions recommended by the Board of Directors were approved by the shareholders at its Combined General Meeting held in Lyon, France.
June 26, 2024
·
4 min read
Press Releases
Valneva to Participate in Multiple Events at the 25th World Vaccine Congress, including a Presentation on its Chikungunya Vaccine IXCHIQ®
April 16, 2025
·
7 min read
Press Releases
Valneva Submits Adolescent Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to UK MHRA
March 31, 2025
·
9 min read
Valneva to Present and Hold Investor Meetings at Upcoming Conferences in June
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that management will participate at several upcoming investor conferences in the United States and Europe during June 2024.
June 4, 2024
·
4 min read
1 of 70,037
Next
